GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » United Therapeutics Corp (FRA:UTH) » Definitions » Cyclically Adjusted Book per Share

United Therapeutics (FRA:UTH) Cyclically Adjusted Book per Share : €64.79 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is United Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

United Therapeutics's adjusted book value per share for the three months ended in Dec. 2023 was €116.667. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €64.79 for the trailing ten years ended in Dec. 2023.

During the past 12 months, United Therapeutics's average Cyclically Adjusted Book Growth Rate was 17.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 20.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 19.20% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 19.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of United Therapeutics was 22.10% per year. The lowest was 17.10% per year. And the median was 18.70% per year.

As of today (2024-04-28), United Therapeutics's current stock price is €221.00. United Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €64.79. United Therapeutics's Cyclically Adjusted PB Ratio of today is 3.41.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of United Therapeutics was 12.58. The lowest was 2.27. And the median was 4.40.


United Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for United Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Cyclically Adjusted Book per Share Chart

United Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.01 33.50 45.01 56.71 64.79

United Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.71 57.54 61.40 66.01 64.79

Competitive Comparison of United Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, United Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, United Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where United Therapeutics's Cyclically Adjusted PB Ratio falls into.



United Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, United Therapeutics's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=116.667/129.4194*129.4194
=116.667

Current CPI (Dec. 2023) = 129.4194.

United Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201403 19.154 99.695 24.865
201406 18.293 100.560 23.543
201409 19.310 100.428 24.884
201412 21.388 99.070 27.940
201503 21.752 99.621 28.258
201506 20.289 100.684 26.080
201509 28.673 100.392 36.964
201512 31.869 99.792 41.330
201603 34.248 100.470 44.116
201606 36.758 101.688 46.782
201609 38.401 101.861 48.790
201612 40.847 101.863 51.897
201703 42.862 102.862 53.928
201706 36.392 103.349 45.572
201709 40.194 104.136 49.953
201712 41.074 104.011 51.108
201803 44.240 105.290 54.379
201806 50.414 106.317 61.369
201809 52.947 106.507 64.337
201812 56.235 105.998 68.661
201903 46.850 107.251 56.534
201906 51.637 108.070 61.838
201909 56.197 108.329 67.138
201912 57.021 108.420 68.065
202003 60.642 108.902 72.067
202006 61.934 108.767 73.694
202009 62.722 109.815 73.919
202012 62.706 109.897 73.845
202103 64.618 111.754 74.832
202106 67.292 114.631 75.973
202109 72.304 115.734 80.854
202112 77.672 117.630 85.457
202203 83.733 121.301 89.337
202206 89.804 125.017 92.967
202209 101.131 125.227 104.517
202212 98.368 125.222 101.665
202303 102.467 127.348 104.134
202306 106.459 128.729 107.030
202309 113.923 129.860 113.537
202312 116.667 129.419 116.667

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


United Therapeutics  (FRA:UTH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

United Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=221.00/64.79
=3.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of United Therapeutics was 12.58. The lowest was 2.27. And the median was 4.40.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


United Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of United Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


United Therapeutics (FRA:UTH) Business Description

Industry
Traded in Other Exchanges
Address
1040 Spring Street, Silver Spring, MD, USA, 20910
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

United Therapeutics (FRA:UTH) Headlines

No Headlines